HOHagen Ott

Hagen Ott

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hagen Ott has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Basophil Activation Test for the Diagnosis of Hymenoptera Venom Allergy in Childhood: a Pilot Study

    by H. Ott, K. Tenbrock, J. Baron, H. Merk, S. Lehmann

    Introduction: Cellular in vitro tests such as the CD63-based basophil activation test (BAT) have been successfully used to diagnose hymenoptera venom sensitization in adult patients while this has not been investigated in children so far. Methods: 15 children (9 male, 6 female; 12.7±3.5 years) with suspected allergy to vespula (VE) or honey bee (HB) venom entered this study. Besides serum tryptase (ST) levels, sensitisation against VE and HB was assessed by titrated skin testing and determination of venom-specific serum IgE (sIgE) in all patients. After stimulation with 50 ng of insect venom, CD63-expression of activated basophils was measured by flow cytometry. Results: Skin testing permitted identification of the culprit insect in 7 patients, 3 cases were diagnosed by additional sIgE measurements. In addition, BAT identified mono-sensitization in 3 further patients with double sensitization upon skin and sIgE testing. Test sensitivity was lower for the BAT (67–75%) than for skin testing (89–100%) and sIgE determination (100%). Neither basophil activation nor sIgE serum levels were identified as reliable predictors of sting reaction severity. In all patients, ST measurements yielded values below the upper reference value. Conclusion: The current pilot study suggests a possible clinical benefit of BAT analysis in the diagnostic workup of pediatric insect venom allergy. However, further large-scale trials are required to investigate whether the BAT reliably contributes to the correct identification of the culprit insect venom. Due to its comparatively low sensitivity, the BAT should currently not be used in isolation from, but only in combination with established diagnostic instruments. Einleitung: Der CD63-basierte Basophilenaktivierungstest (BAT) wird erfolgreich zum Nachweis bei adulten Patienten eingesetzt; entsprechende Daten für das Kindesalter liegen bisher nicht vor. Ziel dieser Pilotstudie war es daher, den klinischen Nutzen des BAT bei Kindern mit Insektengiftallergie zu charakterisieren. Methoden: Retrospektiv wurden 15 Kinder und Jugendliche (9 männlich, 6 weiblich; 12.7±3.5 Lebensjahre) untersucht, die innerhalb von 3 Jahren wegen einer kutanen oder systemischen Bienen- oder Wespenstichreaktion vorgestellt wurden. Es wurden die Reaktionsschwelle durch Hauttestungen mit ansteigenden Hymenopterengiftkonzentrationen ermittelt, insektengiftspezifische IgE-Antikörper (sIgE) und die Serum-tryptase (ST) bestimmt. Die Messung aktivierter (CD63+) basophiler Granulozyten erfolgte durchflusszytometrisch nach Stimulation mit je 50 ng Bienen- und Wespengiftextrakt. Ergebnisse: Bei 7 Patienten erlaubten bereits Hauttestungen eine Bestimmung der auslösenden Insektenart, in 3 weiteren Fällen ließ sich das klinisch relevante Allergen durch zusätzliche sIgE-Bestimmung identifizieren. Ergänzend ergab der BAT bei 3 weiteren Patienten, die in Haut- und FEIA-Testung eine Doppelsensibilisierung aufwiesen, den Befund einer Monosensibilisierung. Die Sensitivität des BAT war mit 67–75% niedriger als die der Hauttestungen (89–100%) und des sIgE (100%). Ein Zusammenhang der Basophilenaktivierung, des sIgE oder der ST mit dem Schweregrad der insektengiftallergischen Reaktion ließ sich nicht nachweisen. Schlussfolgerung: Der BAT stellt auch im Kindesalter eine vielversprechende Ergänzung der etablierten allergologischen Diagnostik dar. Aktuell sollte er jedoch nur komplementär zu den etablierten Testverfahren eingesetzt und in zukünftigen, prospektiven Studien größerer Patientenpopulationen weitergehend evaluiert werden.


  • Soluble immune receptor serum levels are associated with age, but not with clinical phenotype or disease severity in childhood atopic dermatitis

    by H Ott, J Wilke, J M Baron, Ph Höger, R Fölster‐Holst

    Background  Soluble immune receptors (SIRs) have been proposed as biomarkers in patients with atopic dermatitis (AD). However, their clinical applicability in affected children has rarely been studied.Objective  To assess the diagnostic usefulness of serum SIRs in childhood AD by correlating the obtained receptor profiles with serological parameters and clinical features such as age, AD phenotype and disease severity.Methods  We investigated 100 children with AD. The sCD14, sCD23, sCD25, sCD30, total IgE (tIgE) and eosinophilic cationic protein (ECP) were determined using sera of all children. The clinical phenotype was classified as extrinsic AD (ADe) or intrinsic AD (ADi) by the presence of allergen‐specific IgE antibodies.Results  A total of 55 male and 45 female children were recruited. The sCD23, sCD25 and sCD30 serum levels revealed significant age‐dependency. At a mean SCORAD of 40 (range 8–98), none of the evaluated SIRs was correlated to disease severity. In all, 73% of patients suffered from ADe while 27% showed the ADi phenotype. None of the analysed SIRs differed significantly between ADe and ADi patients, while tIgE and ECP levels were elevated in the ADe subgroup.Conclusion  The current study provides evidence that sCD23, sCD25 and sCD30 serum levels are highly age‐dependent. Serum concentrations of all investigated SIRs did not significantly correlate with disease severity in children with AD and were not differentially expressed in patients of different AD phenotypes. Therefore, we believe that the studied SIRs cannot be regarded as clinically useful biomarkers for the assessment of childhood AD.


  • Allergen microarrays: a novel tool for high-resolution IgE profiling in adults with atopic dermatitis

    by Hagen Ott, Regina Fölster-Holst, Hans F Merk, Jens Malte Baron

    Microarray technology has recently been introduced into clinical allergology, but its applicability in adult patients with atopic dermatitis (AD) has not been investigated so far. We aimed to evaluate the utility of allergen microarrays in the diagnostic workup of adults with AD and to compare this new diagnostic tool with a conventional method of specific IgE (sIgE) measurement. In sera of 40 atopic adults, sIgE levels detected by microarray-analysis were correlated with the results of an established fluorescence enzyme immunoassay (FEIA). In a further 20 patients with AD, individual sIgE recognition patterns were established by microarray analysis and evaluated with regard to clinical features of AD. Allergen microarray and FEIA results were significantly correlated (r = 0.72-0.99), especially if recombinant allergens were employed. AD patients revealed a mean of 21 sensitizations per individual (range 1-46) and 65% displayed sIgE against cross-allergens, particularly pathogenesis related proteins such as the major allergen of birch pollen (Bet v 1), alder pollen (Aln g 1), apple (Mal d 1) or celery (Api g 1). The current study provides evidence that allergen microarrays represent a promising tool for component-resolved diagnosis in patients with AD. However, further large-scale studies in unselected patient populations are needed before the introduction of allergen microarrays into daily clinical practice.


    • 1 January 2010
      • Vol. 20  (2) , 129-38

    Microarrays of recombinant Hevea brasiliensis proteins: a novel tool for the component-resolved diagnosis of natural rubber latex allergy.

    by H Ott, C Schröder, M Raulf-Heimsoth, V Mahler, C Ocklenburg, H F Merk, J M Baron

    Component-resolved diagnosis using microarray technology has recently been introduced in clinical allergology, but its applicability in patients with natural rubber latex (NRL) allergy has not been investigated. To evaluate the utility of microarray-based immunoglobulin (Ig) E detection in the diagnostic workup of NRL allergy and to compare this new diagnostic tool with established methods of NRL-specific IgE detection. We investigated 52 adults with immediate-type NRL allergy and 50 control patients. Determination of specific serum IgE against 8 recombinant Hevea brasiliensis allergen components was performed using a customized allergen microarray and a conventional fluorescence enzyme immunoassay (FEIA). The panel of microarrayed allergen components was shown to represent a comprehensive repertoire of clinically relevant NRL proteins. NRL-specific IgE recognition patterns and sensitization rates determined by microarray analysis were similar to those obtained by conventional FEIA. The diagnostic sensitivity rates of combined single-component data were not significantly different for the respective recombinant test system, whereas the sensitivity level of extract-based FEIA analysis was markedly higher. The current study provides evidence that microarrays of recombinant NRL allergen components are a suitable new tool for the diagnosis of NRL-specific sensitization.They show performance characteristics comparable to those of current diagnostic tests and could be indicated in small children in whom only limited blood volumes are obtainable. Further large-scale studies in unselected patient populations and in high-risk groups are warranted before the microarray can be introduced into routine management of patients with NRL allergy.


  • Tacrolimus Modulates Dendritic Cell Activation in the Sensitization Phase of Allergic Contact Dermatitis

    by H. Ott, J.M. Baron, R. Heise, C. Skazik, H.F. Merk

    Background: Knowledge of the effect of topically applied calcineurin antagonists such as tacrolimus on the sensitization phase of allergic contact dermatitis is currently limited. Objective: To investigate tacrolimus-dependent immunomodulation on gene expression alterations in human antigen-presenting cells which are stimulated with small-molecular-weight contact allergens. Methods: Monocyte-derived dendritic cells (moDC) and THP-1 cells were stimulated with the contact sensitizer cinnamic aldehyde (CAld) and compared with the very strong experimental sensitizer 2,4,6-trinitrobenzene sulfonic acid (TNBS) in vitro. Quantitative PCR analysis was used to detect gene expression changes, particularly of interleukin (IL) 8, as an indicator of differential dendritic cell (DC) gene expression after sensitizer stimulation in the absence or presence of tacrolimus and betamethasone at two different concentrations. Results: DC activation was clearly demonstrated by a significant IL-8 upregulation after 24 h, whereas tacrolimus or betamethasone alone did not affect IL-8 baseline expression. Betamethasone and, to a lesser extent, tacrolimus led to a marked reduction of chemical-induced IL-8 expression by TNBS and CAld. Conclusion: The results of the present study support the hypothesis that the calcineurin inhibitor tacrolimus has modulatory effects on human antigen-presenting cells during the sensitization phase of allergic contact dermatitis. In addition, moDC as well as THP-1 cells may serve as a system to study immune-modulating effects of drugs such as glucocorticoids or calcineurin antagonists.


  • Pädiatrische Dermatologie

    by H. Ott, R. Fölster-Holst


  • Cutaneous Metabolic Activation of Carvoxime, a Self-Activating, Skin-Sensitizing Prohapten

    by Hagen Ott, Moa Andresen Bergström, Ruth Heise, Claudia Skazik, Gabriele Zwadlo-Klarwasser, Hans F. Merk, Jens M. Baron, Ann-Therese Karlberg

    Bioactivation of low molecular weight compounds in the skin can cause contact sensitization. We have previously shown that the α,β-unsaturated oxime R-carvoxime [1, (R)-2-methyl-5-isopropenyl-cyclohex-2-enone oxime] is bioactivated to two diastereomeric highly reactive and strongly sensitizing α,β-epoxy oxime metabolites. To investigate if this metabolic activation is catalyzed by the major cytochrome P450 (P450) enzymes found in human skin, incubations of 1 with a skinlike P450 cocktail in the presence of glutathione were carried out. We identified three glutathione conjugates in the incubation mixture arising from two diasteomeric α,β-epoxy oxime metabolites of 1, thus showing that the metabolic activation of 1 is P450-mediated. A P450 identification study using the individual P450 enzymes present in the skinlike P450 cocktail showed the involvement of P450 1A1 and 1B1 and also to some extent 2B6. P450 1B1 metabolism of 1 was found to be stereoselective as glutathione conjugates from only one of the α,β-epoxyoxime metabolites were identified (metabolite 2). Additionally, 1 was found to be an inducer of P450 1B1 (but not 1A1) in human monocyte-derived dendritic cells (moDCs) and to some extent in normal human epidermal keratinocytes. A further transcriptional gene expression change observed in moDCs was a 44-fold upregulation of IL-8, a marker often used for assessment of sensitizing potential of contact allergens. The autoinduction of P450 1B1 by 1 may be a key event in the development of contact allergy to 1 and may also explain why only metabolite 2, and not 3, was found to elicit an allergic response in mice sensitized to 1. Our data show that the α,β-unsaturated oxime 1 is bioactivated by human cutaneous P450, thus forming highly allergenic metabolites, and has the potential to induce its own bioactivation pathway, particularly in antigen-presenting cells.


  • Open Access

    Total Serum IgE as a Parameter to Differentiate Between Intrinsic and Extrinsic Atopic Dermatitis in Children

    by H Ott, S Stanzel, C Ocklenburg, Hf Merk, Jm Baron, S Lehmann

    Atopic dermatitis (AD) has been sub-classified into extrinsic and intrinsic types according to the p...


  • Neonatal and infantile erythrodermas

    by Hagen Ott, Matthias Hütten, Jens Malte Baron, Hans‐Friedrich Merk, Regina Fölster‐Holst

    Summary: The term neonatal or infantile erythroderma designates a generalized erythe‐ma covering more than 90% of the body surface area of neonates and young infants. Erythrodermas are not rare in this age group and have been associated with more than 40 diseases of different degrees of severity.Regardless of the underlying illness, impending acute symptoms of an impaired epidermal barrier function (hypothermia, dehydration, sepsis) must be recognized and treated adequately. Most often patients have to be hospitalized for incubator care and, if necessary, intravenous rehydration and antibiotic therapy.Later a thorough diagnostic workup should be performed in cooperation with specialized centers in order to guarantee a precise diagnosis and the most effective treatment. In particular, potentially severe extracutaneous symptoms require rapid intervention and represent the main focus of this review.